Global Pet Anthelmintic Drugs Market Size, Status and Forecast 2020-2026

August 2020 | 131 pages | ID: G11142313851EN
QYResearch

Abstracts

Pet Anthelmintic Drugs market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Pet Anthelmintic Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
The key players covered in this study

• Elanco
• Boehringer Ingelheim
• Ceva Sante Animale
• Chanelle Group
• Dechra
• Durvet
• First Priority
• Jeffers
• Manna Pro Products
• Merck Animal Health
• Ourofino
• TTK Healthcare
• Vetoquinol
• Virbac
• Zoetis

Market segment by Type, the product can be split into

• External
• Internal
• Composite
• Injection

Market segment by Application, split into

• Dog
• Cat
• Others

Market segment by Regions/Countries, this report covers

• North America
• Europe
• China
• Japan
• Southeast Asia
• India
• Central & South America

Contents

1 REPORT OVERVIEW

1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Pet Anthelmintic Drugs Revenue
1.4 Market by Type
  1.4.1 Global Pet Anthelmintic Drugs Market Size Growth Rate by Type: 2020 VS 2026
  1.4.2 External
  1.4.3 Internal
  1.4.4 Composite
  1.4.5 Injection
1.5 Market by Application
  1.5.1 Global Pet Anthelmintic Drugs Market Share by Application: 2020 VS 2026
  1.5.2 Dog
  1.5.3 Cat
  1.5.4 Others
1.6 Study Objectives
1.7 Years Considered

2 GLOBAL GROWTH TRENDS

2.1 Global Pet Anthelmintic Drugs Market Perspective (2015-2026)
2.2 Global Pet Anthelmintic Drugs Growth Trends by Regions
  2.2.1 Pet Anthelmintic Drugs Market Size by Regions: 2015 VS 2020 VS 2026
  2.2.2 Pet Anthelmintic Drugs Historic Market Share by Regions (2015-2020)
  2.2.3 Pet Anthelmintic Drugs Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
  2.3.1 Market Top Trends
  2.3.2 Market Drivers
  2.3.3 Market Challenges
  2.3.4 Porter’s Five Forces Analysis
  2.3.5 Pet Anthelmintic Drugs Market Growth Strategy
  2.3.6 Primary Interviews with Key Pet Anthelmintic Drugs Players (Opinion Leaders)

3 COMPETITION LANDSCAPE BY KEY PLAYERS

3.1 Global Top Pet Anthelmintic Drugs Players by Market Size
  3.1.1 Global Top Pet Anthelmintic Drugs Players by Revenue (2015-2020)
  3.1.2 Global Pet Anthelmintic Drugs Revenue Market Share by Players (2015-2020)
  3.1.3 Global Pet Anthelmintic Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Pet Anthelmintic Drugs Market Concentration Ratio
  3.2.1 Global Pet Anthelmintic Drugs Market Concentration Ratio (CR5 and HHI)
  3.2.2 Global Top 10 and Top 5 Companies by Pet Anthelmintic Drugs Revenue in 2019
3.3 Pet Anthelmintic Drugs Key Players Head office and Area Served
3.4 Key Players Pet Anthelmintic Drugs Product Solution and Service
3.5 Date of Enter into Pet Anthelmintic Drugs Market
3.6 Mergers & Acquisitions, Expansion Plans

4 MARKET SIZE BY TYPE (2015-2026)

4.1 Global Pet Anthelmintic Drugs Historic Market Size by Type (2015-2020)
4.2 Global Pet Anthelmintic Drugs Forecasted Market Size by Type (2021-2026)

5 MARKET SIZE BY APPLICATION (2015-2026)

5.1 Global Pet Anthelmintic Drugs Market Size by Application (2015-2020)
5.2 Global Pet Anthelmintic Drugs Forecasted Market Size by Application (2021-2026)

6 NORTH AMERICA

6.1 North America Pet Anthelmintic Drugs Market Size (2015-2020)
6.2 Pet Anthelmintic Drugs Key Players in North America (2019-2020)
6.3 North America Pet Anthelmintic Drugs Market Size by Type (2015-2020)
6.4 North America Pet Anthelmintic Drugs Market Size by Application (2015-2020)

7 EUROPE

7.1 Europe Pet Anthelmintic Drugs Market Size (2015-2020)
7.2 Pet Anthelmintic Drugs Key Players in Europe (2019-2020)
7.3 Europe Pet Anthelmintic Drugs Market Size by Type (2015-2020)
7.4 Europe Pet Anthelmintic Drugs Market Size by Application (2015-2020)

8 CHINA

8.1 China Pet Anthelmintic Drugs Market Size (2015-2020)
8.2 Pet Anthelmintic Drugs Key Players in China (2019-2020)
8.3 China Pet Anthelmintic Drugs Market Size by Type (2015-2020)
8.4 China Pet Anthelmintic Drugs Market Size by Application (2015-2020)

9 JAPAN

9.1 Japan Pet Anthelmintic Drugs Market Size (2015-2020)
9.2 Pet Anthelmintic Drugs Key Players in Japan (2019-2020)
9.3 Japan Pet Anthelmintic Drugs Market Size by Type (2015-2020)
9.4 Japan Pet Anthelmintic Drugs Market Size by Application (2015-2020)

10 SOUTHEAST ASIA

10.1 Southeast Asia Pet Anthelmintic Drugs Market Size (2015-2020)
10.2 Pet Anthelmintic Drugs Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Pet Anthelmintic Drugs Market Size by Type (2015-2020)
10.4 Southeast Asia Pet Anthelmintic Drugs Market Size by Application (2015-2020)

11 INDIA

11.1 India Pet Anthelmintic Drugs Market Size (2015-2020)
11.2 Pet Anthelmintic Drugs Key Players in India (2019-2020)
11.3 India Pet Anthelmintic Drugs Market Size by Type (2015-2020)
11.4 India Pet Anthelmintic Drugs Market Size by Application (2015-2020)

12 CENTRAL & SOUTH AMERICA

12.1 Central & South America Pet Anthelmintic Drugs Market Size (2015-2020)
12.2 Pet Anthelmintic Drugs Key Players in Central & South America (2019-2020)
12.3 Central & South America Pet Anthelmintic Drugs Market Size by Type (2015-2020)
12.4 Central & South America Pet Anthelmintic Drugs Market Size by Application (2015-2020)

13KEY PLAYERS PROFILES

13.1 Elanco
  13.1.1 Elanco Company Details
  13.1.2 Elanco Business Overview
  13.1.3 Elanco Pet Anthelmintic Drugs Introduction
  13.1.4 Elanco Revenue in Pet Anthelmintic Drugs Business (2015-2020))
  13.1.5 Elanco Recent Development
13.2 Boehringer Ingelheim
  13.2.1 Boehringer Ingelheim Company Details
  13.2.2 Boehringer Ingelheim Business Overview
  13.2.3 Boehringer Ingelheim Pet Anthelmintic Drugs Introduction
  13.2.4 Boehringer Ingelheim Revenue in Pet Anthelmintic Drugs Business (2015-2020)
  13.2.5 Boehringer Ingelheim Recent Development
13.3 Ceva Sante Animale
  13.3.1 Ceva Sante Animale Company Details
  13.3.2 Ceva Sante Animale Business Overview
  13.3.3 Ceva Sante Animale Pet Anthelmintic Drugs Introduction
  13.3.4 Ceva Sante Animale Revenue in Pet Anthelmintic Drugs Business (2015-2020)
  13.3.5 Ceva Sante Animale Recent Development
13.4 Chanelle Group
  13.4.1 Chanelle Group Company Details
  13.4.2 Chanelle Group Business Overview
  13.4.3 Chanelle Group Pet Anthelmintic Drugs Introduction
  13.4.4 Chanelle Group Revenue in Pet Anthelmintic Drugs Business (2015-2020)
  13.4.5 Chanelle Group Recent Development
13.5 Dechra
  13.5.1 Dechra Company Details
  13.5.2 Dechra Business Overview
  13.5.3 Dechra Pet Anthelmintic Drugs Introduction
  13.5.4 Dechra Revenue in Pet Anthelmintic Drugs Business (2015-2020)
  13.5.5 Dechra Recent Development
13.6 Durvet
  13.6.1 Durvet Company Details
  13.6.2 Durvet Business Overview
  13.6.3 Durvet Pet Anthelmintic Drugs Introduction
  13.6.4 Durvet Revenue in Pet Anthelmintic Drugs Business (2015-2020)
  13.6.5 Durvet Recent Development
13.7 First Priority
  13.7.1 First Priority Company Details
  13.7.2 First Priority Business Overview
  13.7.3 First Priority Pet Anthelmintic Drugs Introduction
  13.7.4 First Priority Revenue in Pet Anthelmintic Drugs Business (2015-2020)
  13.7.5 First Priority Recent Development
13.8 Jeffers
  13.8.1 Jeffers Company Details
  13.8.2 Jeffers Business Overview
  13.8.3 Jeffers Pet Anthelmintic Drugs Introduction
  13.8.4 Jeffers Revenue in Pet Anthelmintic Drugs Business (2015-2020)
  13.8.5 Jeffers Recent Development
13.9 Manna Pro Products
  13.9.1 Manna Pro Products Company Details
  13.9.2 Manna Pro Products Business Overview
  13.9.3 Manna Pro Products Pet Anthelmintic Drugs Introduction
  13.9.4 Manna Pro Products Revenue in Pet Anthelmintic Drugs Business (2015-2020)
  13.9.5 Manna Pro Products Recent Development
13.10 Merck Animal Health
  13.10.1 Merck Animal Health Company Details
  13.10.2 Merck Animal Health Business Overview
  13.10.3 Merck Animal Health Pet Anthelmintic Drugs Introduction
  13.10.4 Merck Animal Health Revenue in Pet Anthelmintic Drugs Business (2015-2020)
  13.10.5 Merck Animal Health Recent Development
13.11 Ourofino
  10.11.1 Ourofino Company Details
  10.11.2 Ourofino Business Overview
  10.11.3 Ourofino Pet Anthelmintic Drugs Introduction
  10.11.4 Ourofino Revenue in Pet Anthelmintic Drugs Business (2015-2020)
  10.11.5 Ourofino Recent Development
13.12 TTK Healthcare
  10.12.1 TTK Healthcare Company Details
  10.12.2 TTK Healthcare Business Overview
  10.12.3 TTK Healthcare Pet Anthelmintic Drugs Introduction
  10.12.4 TTK Healthcare Revenue in Pet Anthelmintic Drugs Business (2015-2020)
  10.12.5 TTK Healthcare Recent Development
13.13 Vetoquinol
  10.13.1 Vetoquinol Company Details
  10.13.2 Vetoquinol Business Overview
  10.13.3 Vetoquinol Pet Anthelmintic Drugs Introduction
  10.13.4 Vetoquinol Revenue in Pet Anthelmintic Drugs Business (2015-2020)
  10.13.5 Vetoquinol Recent Development
13.14 Virbac
  10.14.1 Virbac Company Details
  10.14.2 Virbac Business Overview
  10.14.3 Virbac Pet Anthelmintic Drugs Introduction
  10.14.4 Virbac Revenue in Pet Anthelmintic Drugs Business (2015-2020)
  10.14.5 Virbac Recent Development
13.15 Zoetis
  10.15.1 Zoetis Company Details
  10.15.2 Zoetis Business Overview
  10.15.3 Zoetis Pet Anthelmintic Drugs Introduction
  10.15.4 Zoetis Revenue in Pet Anthelmintic Drugs Business (2015-2020)
  10.15.5 Zoetis Recent Development

14ANALYST'S VIEWPOINTS/CONCLUSIONS

15APPENDIX

15.1 Research Methodology
  15.1.1 Methodology/Research Approach
  15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details

List Of Tables

LIST OF TABLES

Table 1. Pet Anthelmintic Drugs Key Market Segments
Table 2. Key Players Covered: Ranking by Pet Anthelmintic Drugs Revenue
Table 3. Ranking of Global Top Pet Anthelmintic Drugs Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Pet Anthelmintic Drugs Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of External
Table 6. Key Players of Internal
Table 7. Key Players of Composite
Table 8. Key Players of Injection
Table 9. Global Pet Anthelmintic Drugs Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 10. Global Pet Anthelmintic Drugs Market Size by Regions (US$ Million): 2020 VS 2026
Table 11. Global Pet Anthelmintic Drugs Market Size by Regions (2015-2020) (US$ Million)
Table 12. Global Pet Anthelmintic Drugs Market Share by Regions (2015-2020)
Table 13. Global Pet Anthelmintic Drugs Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 14. Global Pet Anthelmintic Drugs Market Share by Regions (2021-2026)
Table 15. Market Top Trends
Table 16. Key Drivers: Impact Analysis
Table 17. Key Challenges
Table 18. Pet Anthelmintic Drugs Market Growth Strategy
Table 19. Main Points Interviewed from Key Pet Anthelmintic Drugs Players
Table 20. Global Pet Anthelmintic Drugs Revenue by Players (2015-2020) (Million US$)
Table 21. Global Pet Anthelmintic Drugs Market Share by Players (2015-2020)
Table 22. Global Top Pet Anthelmintic Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Pet Anthelmintic Drugs as of 2019)
Table 23. Global Pet Anthelmintic Drugs by Players Market Concentration Ratio (CR5 and HHI)
Table 24. Key Players Headquarters and Area Served
Table 25. Key Players Pet Anthelmintic Drugs Product Solution and Service
Table 26. Date of Enter into Pet Anthelmintic Drugs Market
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global Pet Anthelmintic Drugs Market Size by Type (2015-2020) (Million US$)
Table 29. Global Pet Anthelmintic Drugs Market Size Share by Type (2015-2020)
Table 30. Global Pet Anthelmintic Drugs Revenue Market Share by Type (2021-2026)
Table 31. Global Pet Anthelmintic Drugs Market Size Share by Application (2015-2020)
Table 32. Global Pet Anthelmintic Drugs Market Size by Application (2015-2020) (Million US$)
Table 33. Global Pet Anthelmintic Drugs Market Size Share by Application (2021-2026)
Table 34. North America Key Players Pet Anthelmintic Drugs Revenue (2019-2020) (Million US$)
Table 35. North America Key Players Pet Anthelmintic Drugs Market Share (2019-2020)
Table 36. North America Pet Anthelmintic Drugs Market Size by Type (2015-2020) (Million US$)
Table 37. North America Pet Anthelmintic Drugs Market Share by Type (2015-2020)
Table 38. North America Pet Anthelmintic Drugs Market Size by Application (2015-2020) (Million US$)
Table 39. North America Pet Anthelmintic Drugs Market Share by Application (2015-2020)
Table 40. Europe Key Players Pet Anthelmintic Drugs Revenue (2019-2020) (Million US$)
Table 41. Europe Key Players Pet Anthelmintic Drugs Market Share (2019-2020)
Table 42. Europe Pet Anthelmintic Drugs Market Size by Type (2015-2020) (Million US$)
Table 43. Europe Pet Anthelmintic Drugs Market Share by Type (2015-2020)
Table 44. Europe Pet Anthelmintic Drugs Market Size by Application (2015-2020) (Million US$)
Table 45. Europe Pet Anthelmintic Drugs Market Share by Application (2015-2020)
Table 46. China Key Players Pet Anthelmintic Drugs Revenue (2019-2020) (Million US$)
Table 47. China Key Players Pet Anthelmintic Drugs Market Share (2019-2020)
Table 48. China Pet Anthelmintic Drugs Market Size by Type (2015-2020) (Million US$)
Table 49. China Pet Anthelmintic Drugs Market Share by Type (2015-2020)
Table 50. China Pet Anthelmintic Drugs Market Size by Application (2015-2020) (Million US$)
Table 51. China Pet Anthelmintic Drugs Market Share by Application (2015-2020)
Table 52. Japan Key Players Pet Anthelmintic Drugs Revenue (2019-2020) (Million US$)
Table 53. Japan Key Players Pet Anthelmintic Drugs Market Share (2019-2020)
Table 54. Japan Pet Anthelmintic Drugs Market Size by Type (2015-2020) (Million US$)
Table 55. Japan Pet Anthelmintic Drugs Market Share by Type (2015-2020)
Table 56. Japan Pet Anthelmintic Drugs Market Size by Application (2015-2020) (Million US$)
Table 57. Japan Pet Anthelmintic Drugs Market Share by Application (2015-2020)
Table 58. Southeast Asia Key Players Pet Anthelmintic Drugs Revenue (2019-2020) (Million US$)
Table 59. Southeast Asia Key Players Pet Anthelmintic Drugs Market Share (2019-2020)
Table 60. Southeast Asia Pet Anthelmintic Drugs Market Size by Type (2015-2020) (Million US$)
Table 61. Southeast Asia Pet Anthelmintic Drugs Market Share by Type (2015-2020)
Table 62. Southeast Asia Pet Anthelmintic Drugs Market Size by Application (2015-2020) (Million US$)
Table 63. Southeast Asia Pet Anthelmintic Drugs Market Share by Application (2015-2020)
Table 64. India Key Players Pet Anthelmintic Drugs Revenue (2019-2020) (Million US$)
Table 65. India Key Players Pet Anthelmintic Drugs Market Share (2019-2020)
Table 66. India Pet Anthelmintic Drugs Market Size by Type (2015-2020) (Million US$)
Table 67. India Pet Anthelmintic Drugs Market Share by Type (2015-2020)
Table 68. India Pet Anthelmintic Drugs Market Size by Application (2015-2020) (Million US$)
Table 69. India Pet Anthelmintic Drugs Market Share by Application (2015-2020)
Table 70. Central & South America Key Players Pet Anthelmintic Drugs Revenue (2019-2020) (Million US$)
Table 71. Central & South America Key Players Pet Anthelmintic Drugs Market Share (2019-2020)
Table 72. Central & South America Pet Anthelmintic Drugs Market Size by Type (2015-2020) (Million US$)
Table 73. Central & South America Pet Anthelmintic Drugs Market Share by Type (2015-2020)
Table 74. Central & South America Pet Anthelmintic Drugs Market Size by Application (2015-2020) (Million US$)
Table 75. Central & South America Pet Anthelmintic Drugs Market Share by Application (2015-2020)
Table 76. Elanco Company Details
Table 77. Elanco Business Overview
Table 78. Elanco Product
Table 79. Elanco Revenue in Pet Anthelmintic Drugs Business (2015-2020) (Million US$)
Table 80. Elanco Recent Development
Table 81. Boehringer Ingelheim Company Details
Table 82. Boehringer Ingelheim Business Overview
Table 83. Boehringer Ingelheim Product
Table 84. Boehringer Ingelheim Revenue in Pet Anthelmintic Drugs Business (2015-2020) (Million US$)
Table 85. Boehringer Ingelheim Recent Development
Table 86. Ceva Sante Animale Company Details
Table 87. Ceva Sante Animale Business Overview
Table 88. Ceva Sante Animale Product
Table 89. Ceva Sante Animale Revenue in Pet Anthelmintic Drugs Business (2015-2020) (Million US$)
Table 90. Ceva Sante Animale Recent Development
Table 91. Chanelle Group Company Details
Table 92. Chanelle Group Business Overview
Table 93. Chanelle Group Product
Table 94. Chanelle Group Revenue in Pet Anthelmintic Drugs Business (2015-2020) (Million US$)
Table 95. Chanelle Group Recent Development
Table 96. Dechra Company Details
Table 97. Dechra Business Overview
Table 98. Dechra Product
Table 99. Dechra Revenue in Pet Anthelmintic Drugs Business (2015-2020) (Million US$)
Table 100. Dechra Recent Development
Table 101. Durvet Company Details
Table 102. Durvet Business Overview
Table 103. Durvet Product
Table 104. Durvet Revenue in Pet Anthelmintic Drugs Business (2015-2020) (Million US$)
Table 105. Durvet Recent Development
Table 106. First Priority Company Details
Table 107. First Priority Business Overview
Table 108. First Priority Product
Table 109. First Priority Revenue in Pet Anthelmintic Drugs Business (2015-2020) (Million US$)
Table 110. First Priority Recent Development
Table 111. Jeffers Business Overview
Table 112. Jeffers Product
Table 113. Jeffers Company Details
Table 114. Jeffers Revenue in Pet Anthelmintic Drugs Business (2015-2020) (Million US$)
Table 115. Jeffers Recent Development
Table 116. Manna Pro Products Company Details
Table 117. Manna Pro Products Business Overview
Table 118. Manna Pro Products Product
Table 119. Manna Pro Products Revenue in Pet Anthelmintic Drugs Business (2015-2020) (Million US$)
Table 120. Manna Pro Products Recent Development
Table 121. Merck Animal Health Company Details
Table 122. Merck Animal Health Business Overview
Table 123. Merck Animal Health Product
Table 124. Merck Animal Health Revenue in Pet Anthelmintic Drugs Business (2015-2020) (Million US$)
Table 125. Merck Animal Health Recent Development
Table 126. Ourofino Company Details
Table 127. Ourofino Business Overview
Table 128. Ourofino Product
Table 129. Ourofino Revenue in Pet Anthelmintic Drugs Business (2015-2020) (Million US$)
Table 130. Ourofino Recent Development
Table 131. TTK Healthcare Company Details
Table 132. TTK Healthcare Business Overview
Table 133. TTK Healthcare Product
Table 134. TTK Healthcare Revenue in Pet Anthelmintic Drugs Business (2015-2020) (Million US$)
Table 135. TTK Healthcare Recent Development
Table 136. Vetoquinol Company Details
Table 137. Vetoquinol Business Overview
Table 138. Vetoquinol Product
Table 139. Vetoquinol Revenue in Pet Anthelmintic Drugs Business (2015-2020) (Million US$)
Table 140. Vetoquinol Recent Development
Table 141. Virbac Company Details
Table 142. Virbac Business Overview
Table 143. Virbac Product
Table 144. Virbac Revenue in Pet Anthelmintic Drugs Business (2015-2020) (Million US$)
Table 145. Virbac Recent Development
Table 146. Zoetis Company Details
Table 147. Zoetis Business Overview
Table 148. Zoetis Product
Table 149. Zoetis Revenue in Pet Anthelmintic Drugs Business (2015-2020) (Million US$)
Table 150. Zoetis Recent Development
Table 151. Research Programs/Design for This Report
Table 152. Key Data Information from Secondary Sources
Table 153. Key Data Information from Primary Sources

List Of Figures

LIST OF FIGURES

Figure 1. Global Pet Anthelmintic Drugs Market Share by Type: 2020 VS 2026
Figure 2. External Features
Figure 3. Internal Features
Figure 4. Composite Features
Figure 5. Injection Features
Figure 6. Global Pet Anthelmintic Drugs Market Share by Application: 2020 VS 2026
Figure 7. Dog Case Studies
Figure 8. Cat Case Studies
Figure 9. Others Case Studies
Figure 10. Pet Anthelmintic Drugs Report Years Considered
Figure 11. Global Pet Anthelmintic Drugs Market Size YoY Growth 2015-2026 (US$ Million)
Figure 12. Global Pet Anthelmintic Drugs Market Share by Regions: 2020 VS 2026
Figure 13. Global Pet Anthelmintic Drugs Market Share by Regions (2021-2026)
Figure 14. Porter's Five Forces Analysis
Figure 15. Global Pet Anthelmintic Drugs Market Share by Players in 2019
Figure 16. Global Top Pet Anthelmintic Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Pet Anthelmintic Drugs as of 2019
Figure 17. The Top 10 and 5 Players Market Share by Pet Anthelmintic Drugs Revenue in 2019
Figure 18. North America Pet Anthelmintic Drugs Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. Europe Pet Anthelmintic Drugs Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. China Pet Anthelmintic Drugs Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Japan Pet Anthelmintic Drugs Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Southeast Asia Pet Anthelmintic Drugs Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. India Pet Anthelmintic Drugs Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Central & South America Pet Anthelmintic Drugs Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. Bottom-up and Top-down Approaches for This Report
Figure 26. Data Triangulation
Figure 27. Key Executives Interviewed